1. Home
  2. AXR vs UNCY Comparison

AXR vs UNCY Comparison

Compare AXR & UNCY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo AMREP Corporation

AXR

AMREP Corporation

HOLD

Current Price

$25.25

Market Cap

132.0M

Sector

Real Estate

ML Signal

HOLD

Logo Unicycive Therapeutics Inc.

UNCY

Unicycive Therapeutics Inc.

HOLD

Current Price

$5.04

Market Cap

145.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AXR
UNCY
Founded
1961
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Homebuilding
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
132.0M
145.3M
IPO Year
2010
2021

Fundamental Metrics

Financial Performance
Metric
AXR
UNCY
Price
$25.25
$5.04
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
3
Target Price
$30.00
$25.67
AVG Volume (30 Days)
4.9K
2.6M
Earning Date
03-12-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
89.60
N/A
EPS
1.68
N/A
Revenue
$12,831,000.00
$675,000.00
Revenue This Year
$10.12
N/A
Revenue Next Year
N/A
$582.86
P/E Ratio
$15.83
N/A
Revenue Growth
N/A
N/A
52 Week Low
$17.61
$3.72
52 Week High
$29.01
$8.74

Technical Indicators

Market Signals
Indicator
AXR
UNCY
Relative Strength Index (RSI) 47.84 36.91
Support Level $24.60 $4.18
Resistance Level $25.89 $5.20
Average True Range (ATR) 0.90 0.61
MACD 0.03 -0.11
Stochastic Oscillator 22.90 23.87

Price Performance

Historical Comparison
AXR
UNCY

About AXR AMREP Corporation

Amrep Corp through its subsidiaries is engaged in the Real estate business. Its activities include land sales and lease activities, which involve obtaining approvals and selling both developed and undeveloped lots to homebuilders, commercial users, and others, as well as investments in commercial and investment properties. The Company accounts for land sales, home sales, and other revenues. Its operating segments include Land development and Homebuilding. The firm generates a majority of its revenue from the Land development segment. Geographically, all the activities are carried out throughout the United States.

About UNCY Unicycive Therapeutics Inc.

Unicycive Therapeutics Inc is a biotechnology company dedicated to developing treatments for certain medical conditions. It is focusing on kidney diseases. The company's manufactures drug, Renazorb, is a novel phosphate-binding agent being developed for the treatment of hyperphosphatemia. Unicycive's other drug, UNI-494, is a new chemical entity with the issued composition of matter patent protection in late preclinical development for the treatment of acute kidney injury. Company's pipeline comprised of two product candidates: Oxylanthanum Carbonate and UNI-494.

Share on Social Networks: